Latest News

Iktos announces the acquisition of Synsight

Iktos announces the acquisition of Synsight

Iktos announces the acquisition of Synsight.

Read the article07.08.2024

Press release

Iktos announces the acquisition of Synsight
07.08.2024

Iktos announces the acquisition of Synsight

Iktos announces the appointment of Roman Fleck as Chairman
05.02.2024

Iktos announces the appointment of Roman Fleck as Chairman

Iktos and Elsevier announce their partnership
03.05.2024

Iktos and Elsevier announce their partnership

Press articles and news

Artificial intelligence moves forward, cancer retreats

Artificial intelligence moves forward, cancer retreats

A new generation of startups AI-boosted is designing exclusive molecules that could become tomorrow’s cancer treatments. This thematic was central during the last forum Impact santé organized by La Tribune on Thursday. Follow this link to learn more on how Iktos is being part of it.

Read the article
La Tribune |04.29.2024
Artificial intelligence moves forward, cancer retreats
La Tribune | 04.29.2024

Artificial intelligence moves forward, cancer retreats

Interview: Iktos at the AWS summit with BFMTV
BFMTV | 04.04.2024

Interview: Iktos at the AWS summit with BFMTV

Article: Iktos, the French machine that will discover the drugs of tomorrow
Le Point | 03.20.2024

Article: Iktos, the French machine that will discover the drugs of tomorrow

Press Kit

Logos
LogosDownload
Photographies
PhotographiesDownload
Contact

Contact

For any communication need please contact our agency.

Ulysse Communication
Mail :  iktosteam@ulysse-communication.com
Tel. : +33663665922